SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-014390
Filing Date
2022-06-06
Accepted
2022-06-06 16:03:35
Documents
13
Period of Report
2022-06-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20220606_8k.htm   iXBRL 8-K 27260
  Complete submission text file 0001437749-22-014390.txt   160014

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20220603.xsd EX-101.SCH 3600
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20220603_def.xml EX-101.DEF 11531
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20220603_lab.xml EX-101.LAB 15413
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20220603_pre.xml EX-101.PRE 11687
7 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20220606_8k_htm.xml XML 2558
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 22998061
SIC: 2836 Biological Products, (No Diagnostic Substances)